Daniel Tillett
Chief Executive Officer en RACE ONCOLOGY LIMITED .
Fortuna: 12 M $ al 31/03/2024
Perfil
Daniel Tillett founded Nucleics Ltd., where he worked as Chief Executive Officer.
Dr. Tillett also currently works at Race Oncology Ltd., as Chief Executive Officer from 2023.
Dr. Tillett also formerly worked at Race Oncology Ltd., as Executive Director & Chief Scientific Officer from 2020 to 2023 and Simble Solutions Ltd., as Non-Executive Director from 2022 to 2023.
Dr. Tillett received his doctorate degree from the University of New South Wales Built Environment and doctorate degree from School of Biotechnology & Biomolecular Sciences.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RACE ONCOLOGY LTD.
8.16% | 25/08/2023 | 13 480 000 ( 8.16% ) | 12 M $ | 31/03/2024 |
Cargos activos de Daniel Tillett
| Empresas | Cargo | Inicio |
|---|---|---|
| RACE ONCOLOGY LIMITED | Chief Executive Officer | 22/11/2023 |
Antiguos cargos conocidos de Daniel Tillett.
| Empresas | Cargo | Fin |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Director/Board Member | 03/07/2023 |
| RACE ONCOLOGY LIMITED | Chief Tech/Sci/R&D Officer | 23/03/2023 |
| Nucleics Ltd. | Chief Executive Officer | - |
Formación de Daniel Tillett.
| University of New South Wales Built Environment | Doctorate Degree |
| School of Biotechnology & Biomolecular Sciences | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| RACE ONCOLOGY LIMITED | Health Technology |
| SIMBLE SOLUTIONS LIMITED | Technology Services |
| Empresas privadas | 1 |
|---|---|
| Nucleics Ltd. |
- Bolsa de valores
- Insiders
- Daniel Tillett
